EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors

Hayley Vaughn, Heather Major iD, Evangeline Kadera, Kendall Keck, Timothy Dunham, Qining Qian, Bartley Brown, Aaron Scott, Andrew M Bellizzi, Terry Braun, Patrick Breheny iD, Dawn E Quelle iD und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25147532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hayley Vaughn und 13 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Graduate Program in Genetics, University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, DNA Copy Number Variations, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NCI NET SPORE grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Functional copy-number alterations (fCNAs) are DNA copy-number changes with concordant differential gene expression. These are less likely to be bystander genetic lesions and could serve as robust and reproducible tumor biomarkers. To identify candidate fCNAs in neuroendocrine tumors (NETs), we integrated chromosomal microarray (CMA) and RNA-seq differential gene-expression data from 31 pancreatic (pNETs) and 33 small-bowel neuroendocrine tumors (sbNETs). Tumors were resected from 47 early-disease-progression (24 months) patients. Candidate fCNAs that accurately differentiated these groups in this discovery cohort were then replicated using fluorescence in situ hybridization (FISH) on formalin-fixed, paraffin-embedded (FFPE) tissues in a larger validation cohort of 60 pNETs and 82 sbNETs (52 early- and 65 late-disease-progression samples). Logistic regression analysis revealed the predictive ability of these biomarkers, as well as the assay-performance metrics of sensitivity, specificity, and area under the curve. Our results indicate that copy-number changes at chromosomal loci 4p16.3, 7q31.2, 9p21.3, 17q12, 18q21.2, and 19q12 may be used as diagnostic and prognostic NET biomarkers. This involves a rapid, cost-effective approach to determine the primary tumor site for patients with metastatic liver NETs and to guide risk-stratified therapeutic decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsDNA Copy Number VariationsBiomarkers, TumorHumansPrognosisPancreatic NeoplasmsIn Situ Hybridization, FluorescenceFemaleMaleMiddle AgedGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

diagnostic biomarkersfluorescence in situ hybridizationfunctional copy-number alterationsneuroendocrine tumorsrisk-stratifying biomarkers

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Interdisciplinary Graduate Program in Genetics, University of Iowa, Iowa City, IA 52242, USA.
  • Stead Family Department of Pediatrics, University of Iowa Health Care, Iowa City, IA 52242, USA.
  • Department of Surgery, University of Iowa Health Care, Iowa City, IA 52242, USA.
  • Department of Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA.
  • Department of Pathology, University of Iowa, Iowa City, IA 52242, USA.
  • Department of Biostatistics, University of Iowa, Iowa City, IA 52242, USA.

ORCID-Profile: Heather Major, Patrick Breheny, Dawn E Quelle, James R Howe

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NCI NET SPORE grant
  • Interdisciplinary Genetics T32 Predoctoral Training Grant
  • NCI R01 grant
  • Stead Family Department of Pediatrics departmental funds

Zitieren

APA

Vaughn, H., Major, H., Kadera, E., Keck, K., Dunham, T., Qian, Q., Brown, B., Scott, A., Bellizzi, A. M., Braun, T., Breheny, P., Quelle, D. E., Howe, J. R., & Darbro, B. (2024). Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147532

Vancouver

Vaughn H, Major H, Kadera E, Keck K, Dunham T, Qian Q, et al. Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147532

BibTeX
@article{Vaughn2024,
  author = {Vaughn, Hayley and Major, Heather and Kadera, Evangeline and Keck, Kendall and Dunham, Timothy and Qian, Qining and Brown, Bartley and Scott, Aaron and Bellizzi, Andrew M and Braun, Terry and Breheny, Patrick and Quelle, Dawn E and Howe, James R and Darbro, Benjamin},
  title = {Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25147532}
}
Kostenlos starten →